Anthony Doyle Biocryst Pharmaceuticals Inc (BCRX) insider trading activity
Anthony Doyle is Chief Financial Officer of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 259,628 shares of BCRX, which is worth approximately $1.97 Million. The most recent transaction as insider was on Dec 14, 2024, when has been sold 7,890 shares (Common Stock) at a price of $7.53 per share, resulting in proceeds of $59,411. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
260K
2.67%
3M change
14.15%
12M change
Total Value Held
$1.97 Million
Anthony Doyle Transaction History
AD
Anthony Doyle
Chief Financial Officer
Durham, NC